HIGHLIGHTS
- who: Sarah M. Bernhard MD from the Munich, Germany have published the research work: A systematic review of the safety and efficacy of currently used treatment modalities in the treatment of patients with PIK3CA-related overgrowth spectrum, in the Journal: (JOURNAL) of February/13,/2021
- what: The authors evaluated the efficacy and safety of current overgrowth treatment modalities for patients with PROS by performing a systematic review of the current literature.
- how: The characteristics of the included studies are presented in Table II. In the present systematic review the authors identified 16 studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.